Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans

J Biol Chem. 2013 Apr 19;288(16):10953-61. doi: 10.1074/jbc.R112.437038. Epub 2013 Mar 1.

Abstract

A number of genetic disorders are caused by mutations in the genes encoding glycosyltransferases and sulfotransferases, enzymes responsible for the synthesis of sulfated glycosaminoglycan (GAG) side chains of proteoglycans, including chondroitin sulfate, dermatan sulfate, and heparan sulfate. The phenotypes of these genetic disorders reflect disturbances in crucial biological functions of GAGs in human. Recent studies have revealed that mutations in genes encoding chondroitin sulfate and dermatan sulfate biosynthetic enzymes cause various disorders of connective tissues. This minireview focuses on growing glycobiological studies of recently described genetic diseases caused by disturbances in biosynthetic enzymes for sulfated GAGs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Chondroitin Sulfates / biosynthesis
  • Chondroitin Sulfates / genetics*
  • Connective Tissue Diseases* / enzymology
  • Connective Tissue Diseases* / genetics
  • Dermatan Sulfate / biosynthesis
  • Dermatan Sulfate / genetics*
  • Glycosaminoglycans / biosynthesis
  • Glycosaminoglycans / genetics*
  • Heparitin Sulfate / biosynthesis
  • Heparitin Sulfate / genetics*
  • Humans
  • Metabolism, Inborn Errors* / enzymology
  • Metabolism, Inborn Errors* / genetics

Substances

  • Glycosaminoglycans
  • Dermatan Sulfate
  • A73025
  • Chondroitin Sulfates
  • Heparitin Sulfate